Syngen Biotech Co., Ltd.(TW:8279)
NT$81.70+-0.10 (+1.74%)
TW:8279
Syngen Biotech Co., Ltd. Revenue
NT$81.70
At close:+-0.10 (+1.74%)
Syngen Biotech Co., Ltd. (8279) Revenue
Syngen Biotech Co., Ltd. Revenue
Syngen Biotech Co., Ltd. had a revenue of 558.15M in the quarter ending Sep 30, 2026, with -5.94%. This bring the company's revenue in the last twelve months to 2.05B, Decreased 0.25%. In the fiscal year ending Dec 31, 2025, Syngen Biotech Co., Ltd. had annual revenue of 2.14B with 6.10% growth.
- Revenue (ttm)
- 2.05B
- Revenue Growth
- -3.92%
- P/S Ratio
- 1.04
- Revenue/Employee
- TWD 3,856,469
- Employees
- 554
- Market Cap
- TWD 2.21B
Revenue Chart
Syngen Biotech Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.14B | 122.89M | 6.10% |
| Dec 31, 2024 | 2.01B | 176.41M | 9.60% |
| Dec 31, 2023 | 1.84B | -93.41M | -4.84% |
| Dec 31, 2022 | 1.93B | 459.33M | 31.22% |
| Dec 31, 2021 | 1.47B | 159.83M | 12.19% |
| Dec 31, 2020 | 1.31B | 14.17M | 1.09% |
| Dec 31, 2019 | 1.30B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.